NGR-hTNF as second-line treatment in malignant pleural mesothelioma (MPM).
Gilda Rossoni
No relevant relationships to disclose
Vanesa Gregorc
No relevant relationships to disclose
Maria Grazia ViganĂ²
No relevant relationships to disclose
Alessandra Bulotta
No relevant relationships to disclose
Domenico Ghio
No relevant relationships to disclose
Antonio Lambiase
Employment or Leadership Position - MolMed S.p.A.
Claudio Bordignon
Employment or Leadership Position - MolMed S.p.A.